Incyte Corp. Stock
Incyte Corp. Stock
With only a change of €0.040 (0.060%) the Incyte Corp. price is nearly unchanged from yesterday.
We see a rather positive sentiment for Incyte Corp. with 11 Buy predictions and 2 Sell predictions.
With a target price of €105.00 there is a positive potential of 47.265% for Incyte Corp. compared to the current price of €71.30.
Our community identified positive and negative aspects for Incyte Corp. stock for the coming years. 1 users see the criterium "Revenue growth" as a plus for the Incyte Corp. stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Incyte Corp. in the next few years
Pros
1
Revenue growth >5% per year expected
1
EBIT growth >5% per year expected
1
Could be worthwhile Investment >10% per year
Cons
1
Dependend from some customers or products
Performance of Incyte Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Incyte Corp. | 0.060% | 4.395% | 4.948% | -26.369% | 1.713% | 12.842% | 2.312% |
| Sarepta Therapeutics | -0.900% | -2.770% | 2.207% | -56.274% | -52.473% | -45.044% | 349.310% |
| Exact Sciences | 2.610% | 6.139% | 22.936% | 33.549% | -0.075% | 85.885% | 1045.544% |
| Seagen Inc. | -1.520% | 5.255% | 5.656% | -12.500% | -11.780% | 131.869% | 291.637% |
Comments
Other discussions about Incyte Corp. Stock
Trading Incyte Corp.
Trading Incyte Corp.
